EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

TFE3‐rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape

Abbas Agaimy iD, Andres M Acosta iD, Liang Cheng iD, Katrina Collins iD, Eddie Fridman iD, Christoph Schubart, Sean R Williamson iD, Arndt Hartmann, Kiril Trpkov iD

Histopathology · 2024

DOI: 10.1111/his.15304 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Histopathology, 2024. Verfasst von Abbas Agaimy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Comprehensive Cancer Center, European Met…. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Leucine Zipper Transcription Factors, Kidney Neoplasms, Perivascular Epithelioid Cell Neoplasms, Gene Rearrangement. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

A subset of exceptionally rare primary renal perivascular epithelioid cell tumours (PEComas) that harbour Xp11.2 translocation have been reported, but no larger series devoted to this topic have been published. Methods and Results We describe the clinicopathological and molecular features of 10 renal PEComas, collected from our routine and consultation files. There were five female and five male patients aged 14–65 (median: 32 years). One patient had a history of childhood neuroblastoma, but no patients were known to have a tuberous sclerosis complex or other hereditary disorder. Complete surgical excision was the treatment for all patients. The available follow‐up in five patients indicated a favourable outcome in 4/5 cases. Tumour size ranged from 2.8 to 15.2 cm (median, 5.2 cm). Immunohistochemistry revealed consistently strong TFE3 expression in all tumours, whereas PAX8 and keratin cocktails were uniformly negative. Other positive markers included HMB45 (7/9 tumours), CathepsinK (7/9 tumours), and CD117 (KIT) (3/5 tumours). TFE3 rearrangements were detected in 8/9 tumours (by targeted RNA sequencing in seven and by FISH in one). The identified fusion partners included SFPQ ( n = 2) and one tumour each with ASPSCR1 , ZC3H4 , MED15 , RBMX , and PRCC . One tumour that lacked TFE3 rearrangement by next‐generation sequencing (NGS) and fluorescence in situ hybridization (FISH) revealed a large intrachromosomal deletion involving PKD1 and TSC2 by DNA‐based NGS.

Conclusion

This study highlights the morphologic and genetic diversity of TFE3 ‐rearranged primary renal PEComas and underlines the value of surrogate TFE3 immunohistochemistry in identifying them. The lack of PAX8 and keratin expression represents the mainstay for distinguishing these tumours from MiTF‐associated renal cell carcinomas. In addition, we report rare ( ZC3H4 , RBMX ) and novel ( MED15 ) TFE3 fusion partners in PEComa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix Leucine Zipper Transcription FactorsKidney NeoplasmsPerivascular Epithelioid Cell NeoplasmsGene RearrangementHumansMaleFemaleAdultMiddle AgedAgedAdolescentYoung AdultBiomarkers, TumorPhenotypeTranslocation, GeneticIn Situ Hybridization, FluorescenceImmunohistochemistryGene Fusion

Stichwörter der Autor:innen

MiTF pathwayRCCgene fusionsmolecular profilingoncogenestargeted therapy

Substanzen

TFE3 protein, humanBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Institute of Pathology, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Comprehensive Cancer Center, European Metropolitan Area Erlangen-Nuremberg (CCC ER-EMN), Erlangen, Germany.
  • Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Department of Pathology and Laboratory Medicine, Department of Surgery (Urology), Brown University Warren Alpert Medical School, the Legorreta Cancer Center at Brown University and Brown University Health, Providence, R…
  • Department of Diagnostic Pathology, Affiliated to the Faculty of Medicine, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel.
  • Department of Anatomic Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
  • Diagnostic and Molecular Pathology, Alberta Precision Laboratories and University of Calgary, Calgary, AL, Canada.

ORCID-Profile: Abbas Agaimy, Andres M Acosta, Liang Cheng, Katrina Collins, Eddie Fridman, Sean R Williamson, Kiril Trpkov

Zitieren

APA

Agaimy, A., Acosta, A. M., Cheng, L., Collins, K., Fridman, E., Schubart, C., Williamson, S. R., Hartmann, A., & Trpkov, K. (2024). TFE3‐rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape. Histopathology. https://doi.org/10.1111/his.15304

Vancouver

Agaimy A, Acosta AM, Cheng L, Collins K, Fridman E, Schubart C, et al. TFE3‐rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape. Histopathology. 2024. doi:10.1111/his.15304

BibTeX
@article{Agaimy2024,
  author = {Agaimy, Abbas and Acosta, Andres M and Cheng, Liang and Collins, Katrina and Fridman, Eddie and Schubart, Christoph and Williamson, Sean R and Hartmann, Arndt and Trpkov, Kiril},
  title = {TFE3‐rearranged nonmelanotic renal PEComa: a case series expanding their phenotypic and fusion landscape},
  journal = {Histopathology},
  year = {2024},
  doi = {10.1111/his.15304}
}
Kostenlos starten →